Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphoma.
Flamand
V
V
Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Rhode-St-Genèse, Belgium.
Sornasse
T
T
Thielemans
K
K
Demanet
C
C
Leo
O
O
Urbain
J
J
Moser
M
M
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis / Q000276:immunology; D000912:Antibodies, Neoplasm / Q000096:biosynthesis / Q000276:immunology; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology / Q000637:transplantation; D016207:Cytokines / Q000502:physiology; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation*; D005260:Female; D007157:Immunologic Surveillance; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D008954:Models, Biological; D009368:Neoplasm Transplantation; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000473:pathology; D014611:Vaccination
D000888:Antibodies, Anti-Idiotypic; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D016207:Cytokines